Terumo (OTCMKTS:TRUMY) Shares Gap Down - Time to Sell?

Key Points

• Terumo Corp.'s shares experienced a significant gap down, opening at $16.88, compared to the previous close of $17.77.
• Despite a 1.0% decline, Terumo reported a quarterly earnings beat with an EPS of $0.20, exceeding estimates, although revenues of $1.76 billion fell short of the expected $1.80 billion.
• The company has a market capitalization of $26.06 billion and operates in various regions, producing medical products and equipment.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $17.77, but opened at $16.88. Terumo shares last traded at $17.75, with a volume of 3,425 shares.

Terumo Trading Up 0.3%

The company has a quick ratio of 1.53, a current ratio of 2.64 and a debt-to-equity ratio of 0.07. The company has a fifty day moving average of $17.58 and a two-hundred day moving average of $18.21. The stock has a market capitalization of $25.91 billion, a price-to-earnings ratio of 30.70 and a beta of 0.79.

Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. Terumo had a return on equity of 9.19% and a net margin of 12.09%.The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.80 billion.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.